scholarly article | Q13442814 |
P356 | DOI | 10.1097/INF.0B013E31815AC585 |
P698 | PubMed publication ID | 18277934 |
P50 | author | Kate O'Brien | Q6376501 |
Mathuram Santosham | Q56425974 | ||
Ruth A Karron | Q92344448 | ||
P2093 | author name string | Raymond Reid | |
Bhagvanji Thumar | |||
Jana Shaw | |||
Angelia Eick | |||
P433 | issue | 3 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 207-212 | |
P577 | publication date | 2008-03-01 | |
P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
P1476 | title | The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease | |
P478 | volume | 27 |
Q37578458 | A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant |
Q37135395 | Antibody response to respiratory syncytial virus infection in children <18 months old |
Q35915613 | Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study |
Q36263882 | Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age |
Q40959795 | Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells |
Q38162418 | Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity |
Q64060972 | Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease |
Q39256577 | Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis. |
Q36440236 | Impact of Placental Malaria and Hypergammaglobulinemia on Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea |
Q38631747 | In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants. |
Q34360625 | Inflammatory responses to acute pneumovirus infection in neonatal mice |
Q41875572 | Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort |
Q101137473 | Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity |
Q89884849 | Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation |
Q38628928 | New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. |
Q59358180 | Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy |
Q42652733 | Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. |
Q56894869 | Progress in respiratory virus vaccine development |
Q36665660 | Progress toward a Respiratory Syncytial Virus Vaccine |
Q96136323 | Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics |
Q35102554 | Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh |
Q59351084 | Respiratory syncytial virus vaccine: where are we now and what comes next? |
Q35761061 | Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials |
Q38819027 | Strategies to develop vaccines of pediatric interest |
Q38140040 | Translational sciences approach to RSV vaccine development |
Q52652828 | Virus-specific aNtibody, Viral Load and Disease Severity in Respiratory Syncytial Virus Infection. |
Search more.